Pneumococcal vaccine polyvalent

(Pneumovax 23®)

Pneumococcal vaccine polyvalent

Drug updated on 10/23/2023

Dosage FormInjection (intramuscular/subcutaneous: 0.5 mL)
Drug ClassVaccines
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F).

Product Monograph / Prescribing Information

Document TitleYearSource
Pneumovax (pneumococcal vaccine polyvalent) Prescribing Information.2023Merck Sharp & Dohme LLC Rahway, NJ

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines